Braveheart Bio, Inc. (BRVE) vs uniQure N.V. (QURE)
- Braveheart Bio, Inc. BRVE 19.62 −4.29%
- uniQure N.V. QURE 23.81 −3.33%
Braveheart Bio, Inc. and uniQure N.V. are both Biotechnology companies. Braveheart Bio, Inc. and uniQure N.V. are of similar size ($1.8B and $1.7B). Braveheart Bio, Inc. has the higher net margin (0.00% vs −1,154.8%) and the lower return on invested capital (−28.7% vs 0.00%). Across the 12 metrics below, Braveheart Bio, Inc. leads on 10 and uniQure N.V. on 2.
Valuation
Profitability
| Metric | BRVE | QURE | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 93.85% | 67.24% |
| Operating margin | 0.00% | (1,001.74%) | 0.00% |
| Net margin | 0.00% | (1,154.84%) | 0.00% |
| Free cash flow margin | 0.00% | (956.80%) | 0.00% |
| Return on equity | 0.00% | (88.99%) | (50.28%) |
| Return on assets | 0.00% | (25.47%) | (45.89%) |
| Return on invested capital | (28.66%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack